EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Association Between Circulating Gremlin 2 and β‐Cell Function Among Participants With Prediabetes and Type 2 Diabetes

Mengshan Ni, Yanru Chen, Weiqiong Gu iD, Yifei Zhang iD, Min Xu, Yanyun Gu, Yufei Chen iD, Yinmeng Zhu, Xiao Wang, Yaogan Luo, Yu Xu iD, Xu Lin und 3 weitere

Journal of Diabetes · 2025

DOI: 10.1111/1753-0407.70090 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Diabetes, 2025. Verfasst von Mengshan Ni und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong Universit…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Prediabetic State, Insulin-Secreting Cells, Intercellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Shanghai Municipal Education Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Circulating Gremlin 2 (Grem2) has recently been linked to human obesity, but its role in type 2 diabetes (T2D) remains unclear. This study aims to explore the association of circulating Grem2 with β‐cell function.

Methods

A post hoc analysis was conducted using data from three clinical trials, in which all participants underwent the oral glucose tolerance test (OGTT). Circulating Grem2 levels were measured at 0, 1, and 2 h during the OGTT. In Trial 1, Grem2 levels were compared between participants with T2D ( n = 59) and without T2D ( n = 119). We further examined changes in Grem2 levels in response to oral antidiabetic drugs in participants with T2D in Trial 2 ( n = 67) and calorie restriction in participants with prediabetes in Trial 3 ( n = 231). The relationship between Grem2 levels and β‐cell function was analyzed across all trials.

Results

Fasting and 1‐h Grem2 levels were lower in participants with T2D compared with those without T2D (728 ± 25 vs. 649 ± 31 pg/mL, p = 0.020; 631 ± 26 vs. 537 ± 31 pg/mL, p = 0.007). Fasting Grem2 levels were restored after antidiabetic treatment (550 ± 12 vs. 575 ± 12 pg/mL, p = 0.019), and 1‐h Grem2 levels increased following calorie restriction (1118 ± 89 vs. 1144 ± 90 vs. 1253 ± 89 pg/mL, p for trend = 0.002). The 1‐h Grem2 levels were positively associated with β‐cell function assessed by the oral disposition index and HOMA‐β.

Conclusion

Reduced circulating Grem2 levels are associated with impaired β‐cell function in T2D, and could be restored through antidiabetic interventions. Trial Registration: ClinicalTrials.gov : NCT01959984, NCT01758471, NCT03856762

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Prediabetic StateInsulin-Secreting CellsIntercellular Signaling Peptides and ProteinsHumansMaleFemaleMiddle AgedHypoglycemic AgentsGlucose Tolerance TestBlood GlucoseAgedBiomarkersAdultCaloric Restriction

Stichwörter der Autor:innen

Gremlin 2calorie restrictionoral antidiabetic drugprediabetestype 2 diabetesβ‐cell function

Substanzen

Intercellular Signaling Peptides and ProteinsHypoglycemic AgentsBlood GlucoseBiomarkers

Autor:innen und Institutionen

  • Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medici…
  • Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
  • Key Laboratory of Systems Biology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Hangzhou, China.
  • State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, University of Chinese Academy of Sciences, Shanghai, China.

ORCID-Profile: Weiqiong Gu, Yifei Zhang, Yufei Chen, Yu Xu, Jiqiu Wang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Shanghai Municipal Education Commission
  • Program of Shanghai Academic Research Leader

Zitieren

APA

Ni, M., Chen, Y., Gu, W., Zhang, Y., Xu, M., Gu, Y., Chen, Y., Zhu, Y., Wang, X., Luo, Y., Xu, Y., Lin, X., Zeng, Y. A., Liu, R., & Wang, J. (2025). Association Between Circulating Gremlin 2 and β‐Cell Function Among Participants With Prediabetes and Type 2 Diabetes. Journal of Diabetes. https://doi.org/10.1111/1753-0407.70090

Vancouver

Ni M, Chen Y, Gu W, Zhang Y, Xu M, Gu Y, et al. Association Between Circulating Gremlin 2 and β‐Cell Function Among Participants With Prediabetes and Type 2 Diabetes. Journal of Diabetes. 2025. doi:10.1111/1753-0407.70090

BibTeX
@article{Ni2025,
  author = {Ni, Mengshan and Chen, Yanru and Gu, Weiqiong and Zhang, Yifei and Xu, Min and Gu, Yanyun and Chen, Yufei and Zhu, Yinmeng and Wang, Xiao and Luo, Yaogan and Xu, Yu and Lin, Xu and Zeng, Yi Arial and Liu, Ruixin and Wang, Jiqiu},
  title = {Association Between Circulating Gremlin 2 and β‐Cell Function Among Participants With Prediabetes and Type 2 Diabetes},
  journal = {Journal of Diabetes},
  year = {2025},
  doi = {10.1111/1753-0407.70090}
}
Kostenlos starten →